Yamazaki N - Search Results

1

Japanese real-world study of sequential nivolumab and ipilimumab treament in melanoma.

Tsutsumida A, Fukushima S, Yokota K, Yoshikawa S, Yamasaki O, Tanemura A, Okuyama R, Uhara H, Muto Y, Miyashita A, Akiyama M, Kaji T, Koga H, Kato J, Katayama T, Itakura E, Yamazaki N, Kiyohara Y. Tsutsumida A, et al. Among authors: yamazaki n. J Dermatol. 2019 Nov;46(11):947-955. doi: 10.1111/1346-8138.15073. Epub 2019 Sep 17. J Dermatol. 2019. PMID: 31531895

2

[Chemotherapy of malignant melanoma].

Ishihara K, Yamazaki N, Asano K. Ishihara K, et al. Among authors: yamazaki n. Gan To Kagaku Ryoho. 1993 Aug;20(10):1287-92. Gan To Kagaku Ryoho. 1993. PMID: 7688498 Japanese.

3

Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients.

Kuno Y, Ishihara K, Yamazaki N, Mukai K. Kuno Y, et al. Among authors: yamazaki n. Jpn J Clin Oncol. 1996 Jun;26(3):144-51. doi: 10.1093/oxfordjournals.jjco.a023198. Jpn J Clin Oncol. 1996. PMID: 8656554

4

A case of metastatic extramammary Paget's disease that responded to combination chemotherapy.

Yamazaki N, Yamamoto A, Wada T, Ishikawa M, Moriya Y, Nakanishi Y. Yamazaki N, et al. J Dermatol. 1999 May;26(5):311-6. doi: 10.1111/j.1346-8138.1999.tb03477.x. J Dermatol. 1999. PMID: 10380432

5

Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.

Yamazaki N, Yamamoto A, Wada T, Ishikawa M. Yamazaki N, et al. J Dermatol. 1999 Aug;26(8):489-93. doi: 10.1111/j.1346-8138.1999.tb02033.x. J Dermatol. 1999. PMID: 10487002

6

Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience.

Wakamatsu K, Kageshita T, Furue M, Hatta N, Kiyohara Y, Nakayama J, Ono T, Saida T, Takata M, Tsuchida T, Uhara H, Yamamoto A, Yamazaki N, Naito A, Ito S. Wakamatsu K, et al. Among authors: yamazaki n. Melanoma Res. 2002 Jun;12(3):245-53. doi: 10.1097/00008390-200206000-00008. Melanoma Res. 2002. PMID: 12140381

7

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Among authors: yamazaki n. Int J Oncol. 2008 Sep;33(3):433-41. Int J Oncol. 2008. PMID: 18695871

8

Identification of melanoma antigens using a Serological Proteome Approach (SERPA).

Suzuki A, Iizuka A, Komiyama M, Takikawa M, Kume A, Tai S, Ohshita C, Kurusu A, Nakamura Y, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Akiyama Y. Suzuki A, et al. Among authors: yamazaki n. Cancer Genomics Proteomics. 2010 Jan-Feb;7(1):17-23. Cancer Genomics Proteomics. 2010. PMID: 20181627

9

Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.

Iizuka A, Komiyama M, Tai S, Oshita C, Kurusu A, Kume A, Ozawa K, Nakamura Y, Ashizawa T, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Yamaguchi K, Akiyama Y. Iizuka A, et al. Among authors: yamazaki n. Immunol Lett. 2011 Mar 30;135(1-2):64-73. doi: 10.1016/j.imlet.2010.09.013. Epub 2010 Oct 12. Immunol Lett. 2011. PMID: 20932861

10

Clinicopathological significance of sentinel node biopsy in Japanese patients with cutaneous malignant melanoma.

Noro S, Yamazaki N, Nakanishi Y, Yamamoto A, Sasajima Y, Kawana S. Noro S, et al. Among authors: yamazaki n. J Dermatol. 2011 Jan;38(1):76-83. doi: 10.1111/j.1346-8138.2010.01002.x. Epub 2010 Sep 17. J Dermatol. 2011. PMID: 21175760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

781 results

Search Page

Filters